KEGG pathway enrichment analysis showed 182 signaling pathways, including the PI3K-Akt, TNF, IL17, apoptosis, NAFLD, and lipid and atherosclerosis signaling pathways (Figure 4c). This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.